Enantigen Therapeutics — SBIR/STTR Competitive Profile

Aggregate SBIR/STTR award history for Enantigen Therapeutics, built entirely from public federal award records. Free competitive intelligence — no login required.

Phase mix

Funding agencies

Awards by year

Places of performance

Firms like Enantigen Therapeutics

See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.

Recent awards

AwardAgencyAmountProgramStart
W911NF-12-C-0007 Department of Defense $738,292 STTR · Phase II 2011-12-16
1R43AI098200-01A1 Department of Health and Human Services $300,000 SBIR · Phase I
1R43AI104086-01A1 Department of Health and Human Services $300,000 SBIR · Phase I
1R43AI104066-01 Department of Health and Human Services $294,674 SBIR · Phase I

Frequently asked questions

How many SBIR/STTR awards has Enantigen Therapeutics won?

Enantigen Therapeutics has won 4 SBIR/STTR awards worth $1,632,966 in the public federal award records SBIR Signal tracks, including 3 Phase I and 1 Phase II award(s).

Which agencies fund Enantigen Therapeutics?

Enantigen Therapeutics's awards come from 2 agencies on record; its top funder is Department of Health and Human Services.

What technology areas does Enantigen Therapeutics work in?

Based on its award history, Enantigen Therapeutics works in a range of technology areas.

How do I find firms similar to Enantigen Therapeutics?

Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.